These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 18156614

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, Hansen ML, Folke F, Buch P, Madsen M, Vaag A, Torp-Pedersen C.
    Circulation; 2008 Apr 15; 117(15):1945-54. PubMed ID: 18378618
    [Abstract] [Full Text] [Related]

  • 5. Effect of gender on prognosis in patients with myocardial infarction and type 2 diabetes.
    Venskutonyte L, Malmberg K, Norhammar A, Wedel H, Rydén L.
    J Intern Med; 2010 Jul 15; 268(1):75-82. PubMed ID: 20210844
    [Abstract] [Full Text] [Related]

  • 6. [Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].
    Gustafsson I, Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt PR, MacLeod K, Laakso M, Torp-Pedersen CT, Waldenström A, DIGAMI-2 investigatorerne.
    Ugeskr Laeger; 2006 Feb 06; 168(6):581-4. PubMed ID: 16476220
    [Abstract] [Full Text] [Related]

  • 7. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ, Deifuss S, Klamann A, Schmiegel W, Nauck MA, LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Exp Clin Endocrinol Diabetes; 2003 Sep 06; 111(6):344-50. PubMed ID: 14520601
    [Abstract] [Full Text] [Related]

  • 8. The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial.
    Mellbin LG, Malmberg K, Rydén L, Wedel H, Vestberg D, Lind M.
    Eur Heart J; 2013 Feb 06; 34(5):374-9. PubMed ID: 23144046
    [Abstract] [Full Text] [Related]

  • 9. Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study.
    Horsdal HT, Mehnert F, Rungby J, Johnsen SP.
    J Stroke Cerebrovasc Dis; 2012 Nov 06; 21(8):717-25. PubMed ID: 21536457
    [Abstract] [Full Text] [Related]

  • 10. Coronary heart disease outcomes in patients receiving antidiabetic agents.
    McAfee AT, Koro C, Landon J, Ziyadeh N, Walker AM.
    Pharmacoepidemiol Drug Saf; 2007 Jul 06; 16(7):711-25. PubMed ID: 17551989
    [Abstract] [Full Text] [Related]

  • 11. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.
    Schramm TK, Gislason GH, Vaag A, Rasmussen JN, Folke F, Hansen ML, Fosbøl EL, Køber L, Norgaard ML, Madsen M, Hansen PR, Torp-Pedersen C.
    Eur Heart J; 2011 Aug 06; 32(15):1900-8. PubMed ID: 21471135
    [Abstract] [Full Text] [Related]

  • 12. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.
    Nilsson PM, Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Fagard R, Gudbjörnsdóttir S, Swedish National Diabetes Register.
    Eur J Cardiovasc Prev Rehabil; 2009 Aug 06; 16(4):506-12. PubMed ID: 19561510
    [Abstract] [Full Text] [Related]

  • 13. Glucose-lowering therapy after myocardial infarction: more questions than answers.
    Radke PW, Schunkert H.
    Eur Heart J; 2008 Jan 06; 29(2):141-3. PubMed ID: 18199566
    [Abstract] [Full Text] [Related]

  • 14. Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study.
    Mellbin LG, Malmberg K, Norhammar A, Wedel H, Rydén L, DIGAMI 2 Investigators.
    Diabetologia; 2011 Jun 06; 54(6):1308-17. PubMed ID: 21359582
    [Abstract] [Full Text] [Related]

  • 15. Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial.
    Mellbin LG, Malmberg K, Waldenström A, Wedel H, Rydén L, DIGAMI 2 investigators.
    Heart; 2009 May 06; 95(9):721-7. PubMed ID: 19029171
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Leptin: a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes.
    Wallander M, Söderberg S, Norhammar A.
    Diabet Med; 2008 Aug 06; 25(8):949-55. PubMed ID: 18959608
    [Abstract] [Full Text] [Related]

  • 19. IGF binding protein 1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetes.
    Wallander M, Norhammar A, Malmberg K, Ohrvik J, Rydén L, Brismar K.
    Diabetes Care; 2007 Sep 06; 30(9):2343-8. PubMed ID: 17563335
    [Abstract] [Full Text] [Related]

  • 20. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.
    Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM.
    Circulation; 2005 Feb 08; 111(5):583-90. PubMed ID: 15699279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.